Tiziana Life Sciences Ltd (TLSA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $72.53M
Last updated: Nov 17, 2026 at 11:06 AM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 37.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 29.1, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Data
Related GNG Research
No research available
Be the first to write about TLSA
GNG News
All TLSA news- TLSABTIG starts coverage of Tiziana Life Sciences (TLSA) at Buy
UpdatedHistorical
News
TLSA Valuation
- P/B
- -26.8x
TLSA Profitability: Margins, ROIC and FCF
Tiziana Life Sciences (TLSA) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -781.0%
Tiziana Life Sciences Competitors
The companies most similar to Tiziana Life Sciences (TLSA) include vTv Therapeutics, Kazia Therapeutics Ltd ADR and Oncolytics Biotech.
Sector: Healthcare
TLSA Bull Case vs Bear Case
Bear case
- TLSA beat EPS estimates in 12.5% of its last 8 reported quarters.
TLSA Earnings: Beat Rate
- Beat rate
- 1 of 8 quarters (12.5%)
- Average surprise
- -61.2%
Updated Nov 4, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About TLSA
Does TLSA pay dividends?
Tiziana Life Sciences Ltd (TLSA) does not currently pay a regular dividend.
What is TLSA's market cap?
Tiziana Life Sciences Ltd (TLSA) has a market capitalization of $72.53M with a current stock price of $0.58.
TLSA pages: Overview
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.